Cipla receives regulatory approval to distribute Moderna COVID-19 vaccine

Cipla Ltd has received regulatory approval to distribute partner Moderna Inc’s COVID-19 vaccine in the country, a senior government official said on Tuesday, clearing the way for the shot to be imported.

Moderna’s vaccine will be the fourth shot authorized for use in India, after AstraZeneca and partner Serum Institute of India’s Covishield, Bharat Biotech’s Covaxin and Sputnik V developed by Russia’s Gamaleya Institute reported Reuters.

“Our vaccine basket is now richer by this addition,” government official Vinod Kumar Paul said at a news briefing on Tuesday, adding the government remained in talks with Pfizer over the drugmaker’s vaccine.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker